# The Moran AMD Genetic Testing Assessment Study

> **NCT05265624** · PHASE2 · COMPLETED · sponsor: **Paul S. Bernstein** · enrollment: 80 (actual)

## Conditions studied

- Age-Related Macular Degeneration
- Genetic Testing
- Nutritional Biomarkers

## Interventions

- **BEHAVIORAL:** Early disclosure of genetic testing results
- **BEHAVIORAL:** Late disclosure of genetic testing results

## Key facts

- **NCT ID:** NCT05265624
- **Lead sponsor:** Paul S. Bernstein
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-03
- **Primary completion:** 2024-07-12
- **Final completion:** 2024-07-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05265624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05265624, "The Moran AMD Genetic Testing Assessment Study". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05265624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*